Podcasts about controversies

"Tragedy pimps" fallout, talking Hallmark movies with Amelia Hamilton (from Growing Patriots and A Very Merry Podcast) , Dave Chappelle and Kyrie Irving controversies

The Supreme Court's first oral argument sitting of the new term is in the books as the nine-case docket included disputes over state secrets and the Boston Marathon bombing. The MacArthur Justice Center's Amir Ali joins Bloomberg Law's Cases and Controversies podcast to talk about what it was like to argue in the high court's new hybrid, in-person format. Ali represented the petitioner in Thompson v. Clark, a case about federal civil rights lawsuits that led Justice Samuel Alito to pose a hypothetical question about a half man/half horse with a nicotine addiction. Seriously.

Is it appropriate – even a good thing in this time of intense political division -- for social studies teachers to bring politics, current events, and highly controversial issues into the classroom? Diana Hess is a former social studies teacher, now Dean of the College of Education at the University of Wisconsin, and a nationally recognized expert on civic education. Drawing upon extensive research on classroom practices, she argues that in a democratic society these topics must be part of the curriculum and that teachers can (and most often do) discuss them without being partisan.

Big O looks at the controversies being discussed with Miami Dolphins

Ben & Woods kick off Monday's show welcoming Paul back to the studio after a couple weeks of nursing his wife Megan back to health. Then we discuss the MLB playoffs including a couple of big controversies from last night's games before catching up with senior NFL writer Eric Adelson for our NFL Insider Report! Listen here! See omnystudio.com/listener for privacy information.

Oratorian brother and visual artist Joshua Vargas joins Thomas and James to discuss Season 2 of The Chosen. The series continues to set a high imaginative standard in its portrayal of the Twelve Apostles, each of whom has a distinctive personality and several of whom have beautifully fleshed-out backstories (the calling of Nathanael being one of the standout episodes of this season). Jonathan Roumie continues to shine in his performance as Jesus, and we also find the filmmakers stretching their cinematic chops and experimenting with various methods of storytelling. The Protestant-written show also ventured into more problematic theological territory this season, so a review would be incomplete without an evaluation of its controversial treatment of the Virgin Mary and of Jesus' human knowledge. While falling short of a Catholic view, these allow for some nuance; but the portrayal of John the Baptist is purely disappointing. Watch discussion on YouTube: https://youtu.be/iREGf8C6_tM Links The Chosen, Season 1 discussion https://www.catholicculture.org/commentary/chosen-education-in-meditation/ Thomas's interview with Jonathan Roumie on the Catholic Culture Podcast https://www.catholicculture.org/commentary/ep-76-playing-jesus-on-chosen-jonathan-roumie/ Buy Brother Joshua's work on Etsy https://www.etsy.com/shop/ArtbyJoshuaVargas Music is The Duskwhales, “Take It Back”, used with permission. https://theduskwhales.bandcamp.com/ This podcast is a production of CatholicCulture.org. If you like the show, please consider supporting us! http://catholicculture.org/donate/audio

Tega Dominic sits with Chude Jideonwo for a tell-it-all on everything that's happened in the house, life after BBN and where things are with her husband.Watch the full episode here: http://watch.withchude.comListen to the extended play podcast here: https://listen.withchude.comBuy #TheDailyVulnerable book here: shop.withchude.comSponsor a subscription for people who can't afford it here: partner.withchude.comDonate to the work via Patreon here: partner.withchude.com  Partner with us through your institution or organization here: partner.withchude.com  Please subscribe to our YouTube Channel: https://youtube.com/c/chude WithChude is a special series of targeted multimedia (video, audio, text, event) conversations and investigations that leverage the voice, network and passion of its host, Chude Jideonwo and his interviews, to underline social issues, raise social consciousness and spark social movements.Focused on narratives that enable and strengthen the mind (mental health), heart (emotional health) and spirit (spiritual health), its themes center on empathy, compassion, mindfulness, wellness, and food for the soul.#WithChude is a project of YNaija TV in partnership with Joy, Inc.For inquiries or issues with the platform, please call +2349035998080 or email info@withchude.com.#WithChude#MindHeartSpirit#LetsBeHumanTogether See acast.com/privacy for privacy and opt-out information.

Maria and Julio give a brief update on the latest in Congress. Then they get into the outage across Facebook's platforms this week and the congressional testimony from whistleblower, Frances Haugen. They also talk about the scandals emerging around Ozy Media, and the Pandora Papers leak.ITT Staff Picks: Billy Perrigo reports for Time Magazine about Facebook's decision to shut down its civic-integrity team, and the reckoning that followed. Read more from Lauren Williams, CEO of Capital B, about the scandal surrounding Ozy Media, via New York Times Opinion.Elías Camhaji reports about the Spanish and Latino artists revealed in the Pandora Papers in this piece for El País. Photo credit: AP Photo/Richard Drew See acast.com/privacy for privacy and opt-out information.

Dave and Ethan interview "WEIRD AL" YANKOVIC himself in this no-holds-barred conversation that covers anything and everything from his entire 40+ year career.

SEC Network host and reporter Alyssa Lang takes time away from a full plate of work to join Andy in a full course SEC discussion. Antipasto: Will Levis food challenges, controversy & favorite on-air eats Primi: SEC fanbases ready to turn on their coaches Secondi: A&M's struggles & Florida's ceiling Contori: Let Bo Go & Georiga's devastating defense Dolce: Local TV reporter lyfe Follow Andy on Twitter: @Andy_Staples Follow Alyssa on Twitter: @AlyssaLang Save 50% on a subscription to The Athletic by visiting: theathletic.com/andystaples Learn more about your ad choices. Visit megaphone.fm/adchoices

Moderator: Shane M. Hollawell, DPM, FACFAS Panelists: Michael D. Dujela, DPM, FACFAS; Christopher L. Reevees, DPM, MS, FACFAS, Naohiro Shibuya, DPM, MS, FACFAS Release Date: October 1, 2021 Run Time: 38min 57sec

In-person arguments will resume at the U.S. Supreme Court Oct. 4 after the courthouse was shuttered for the past year and a half due to Covid-19. Attendance in the courtroom is limited to staff, arguing attorneys, and a handful of journalists, so the court will continue to livestream the proceedings to the public.  For this episode of Cases & Controversies, Kimberly Robinson and Jordan Rubin run down the five cases the justices will hear during their first week, including a battle between states over water rights and the federal government's attempt to block "state secrets" from being handed over to litigants.

(00:00) Local News Chat: Oshkosh Superintendent & UWO Enrollment (19:30) Your Take on Efforts to Remove Controvesies From Classrooms (40:30) Josh Schoemann, Washington County Executive (58:00) Mike & Manny on the Local Economy, w Barb LaMue, NEW North (90:30) The Takeaway: Self-Serving Inconsistency From Partisans

We're up after WWE RAW with first impressions, pro wrestling news, Lego updates, and the latest pop culture on our minds live from Sorgatron Media Studio in Pittsburgh, PA! Sorg, Mad Mike and Just Pro Wrestling News's Mainstream Matt talk about youth baseball, WWE Raw, Goofy Movie controversy, pro wrestling video production and more! www.WrestlingMayhemShow.comWrestling Mayhem Show Super Feed: https://wmssuperfeed.fireside.fm/Sorgatron Media Podcast Network Feed: http://sorgatronmedia.fireside.fm/ • • • • • wweraw #wwe #wwenetwork #wwesmackdown #wrestlemania #romanreigns #prowrestling #undertaker #smackdown #wrestling #ajstyles #raw #NXT #SethRollins #DeanAmbrose #RandyOrton #johncena #BrockLesnar #wwenxt #cmpunk #tripleh #WWF #DanielBryan #allelitewrestling #aew #aewdynamite #nxt #TheRock #njpw #jonmoxley

The Rockies celebrated Larry Walker this weekend, retiring his number and reflecting on his career. While there were positives and cheerful moments from the celebration, stories from the fan experience show another example of mismanagement and poor planning by Rockies front office. Plus, the Giants dominated the Rockies, where has the home offense gone? The lack of runs is something that has to be fixed this offseason. Follow the show on Twitter @LORockies and the host Paul Holden @PaulHolden33 Support Us By Supporting Our Sponsors! Built Bar Built Bar is a protein bar that tastes like a candy bar. Go to builtbar.com and use promo code “LOCKED15,” and you'll get 15% off your next order. BetOnline AG There is only 1 place that has you covered and 1 place we trust. Betonline.ag! Sign up today for a free account at betonline.ag and use that promocode: LOCKEDON for your 50% welcome bonus. Rock Auto Amazing selection. Reliably low prices. All the parts your car will ever need. Visit RockAuto.com and tell them Locked On sent you. Learn more about your ad choices. Visit podcastchoices.com/adchoices

* Episode was pre-recorded* This week Addison sat down and spoke with North Creek High School Senior, Oliver Ward. Oliver is a baseball player who is committed to playing at Everett Community College. They discussed what it took to be on Varsity freshman year, what it means to be a team captain, how to keep your pitching arm healthy, and much more.

When Supreme Court justices return to the courtroom for the new term in October, they'll consider the government's quest to reinstate Boston Marathon bomber Dzhokhar Tsarnaev's death sentences. The court will hear arguments on Oct. 13 about pretrial publicity and mitigating evidence, as the justices decide whether to reverse an appeals court ruling that vacated Tsarnaev's sentences for the 2013 bombing that killed three people and injured hundreds more. Attorney General Merrick Garland imposed an execution moratorium this past summer, raising the question of how that will play into the case, if at all. To help break down the issues, “Cases and Controversies” hosts Kimberly Robinson and Jordan Rubin are joined by Goodwin's William Jay, who filed an amicus brief supporting the government on behalf of the National Fraternal Order of Police. Hosts: Kimberly Robinson and Jordan Rubin Guest: William Jay Producer: David Schultz Listen and subscribe to Cases and Controversies from your mobile device: Via Apple Podcasts | Via Stitcher | Via Overcast | Via Spotify

Indonesia's corruption eradication commission, known as the KPK has widely been considered one of the most powerful and successful anti-corruption agencies in the region, if not in the entire world. Yet over the past years, it has been systematically undermined from above. One of the most devastating developments was a revision of the law on the KPK. The law effectively stripped the KPK of autonomy in important investigative functions and in its human resources management. It culminated earlier this summer, when a number of key investigators were purged from the KPK. Kenneth Bo Nielsen (coordinator of the Norwegian Network for Asian Studies) is joined by Sofie Schütte - senior researcher at the U4 Anti-corruption Resource Centre at Christian Michelsen Institute in Norway, to discuss the turbulence and controversies surrounding the KPK, her experience with academic work on anti-corruption and the future of anti-corruption in Indonesia. The Nordic Asia Podcast is a collaboration sharing expertise on Asia across the Nordic region, brought to you by the Nordic Institute of Asian Studies (NIAS) based at the University of Copenhagen, along with our academic partners: the Centre for East Asian Studies at the University of Turku, Asianettverket at the University of Oslo, and the Stockholm Centre for Global Asia at Stockholm University. We aim to produce timely, topical and well-edited discussions of new research and developments about Asia. Transcripts of the Nordic Asia Podcasts: http://www.nias.ku.dk/nordic-asia-podcast About NIAS: www.nias.ku.dk Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

We cover all the crazy things we remember most from the 80s and our childhood! Controversies, impactful events, and also some downright weird things that happened --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/ilivedthe80spodcast/support

On this episode of Older and Wiser, Bob Bates and Susan Sikora explore recent public opinion surveys.   This week, how many believe we're heading to civil war, and don't most Republicans don't trust the news media.  Also, favorite Halloween treats, and answers to disputed questions about food.   

CrossFit competition has never been without some good controversy along the way. Bill and Chase sit down and talk about their Top 5 CrossFit Games Controversies from the Open, Regionals and CrossFit Games over the last 15 years.. This is an exclusive commercial free episode for our patreon supporters aka "Programatrons". If you wish to hear this audio in full then got to patreon.com/getwiththeprogramming and for $6 a month you support to show and get exclusive content, free workouts and apparel discounts

Full Text of ReadingsFriday of the Twenty-fourth Week in Ordinary Time Lectionary: 447All podcast readings are produced by the USCCB and are from the Catholic Lectionary, based on the New American Bible and approved for use in the United States _______________________________________The Saint of the day is Saint Robert BellarmineWhen Robert Bellarmine was ordained in 1570, the study of Church history and the fathers of the Church was in a sad state of neglect. A promising scholar from his youth in Tuscany, he devoted his energy to these two subjects, as well as to Scripture, in order to systematize Church doctrine against the attacks of the Protestant Reformers. He was the first Jesuit to become a professor at Louvain. His most famous work is his three-volume Disputations on the Controversies of the Christian Faith. Particularly noteworthy are the sections on the temporal power of the pope and the role of the laity. Bellarmine incurred the anger of monarchists in England and France by showing the divine-right-of-kings theory untenable. He developed the theory of the indirect power of the pope in temporal affairs; although he was defending the pope against the Scottish philosopher Barclay, he also incurred the ire of Pope Sixtus V. Bellarmine was made a cardinal by Pope Clement VIII on the grounds that “he had not his equal for learning.” While he occupied apartments in the Vatican, Bellarmine relaxed none of his former austerities. He limited his household expenses to what was barely essential, eating only the food available to the poor. He was known to have ransomed a soldier who had deserted from the army and he used the hangings of his rooms to clothe poor people, remarking, “The walls won't catch cold.” Among many activities, Bellarmine became theologian to Pope Clement VIII, preparing two catechisms which have had great influence in the Church. The last major controversy of Bellarmine's life came in 1616 when he had to admonish his friend Galileo, whom he admired. He delivered the admonition on behalf of the Holy Office, which had decided that the heliocentric theory of Copernicus was contrary to Scripture. The admonition amounted to a caution against putting forward—other than as a hypothesis—theories not yet fully proven. This shows that saints are not infallible. Robert Bellarmine died on September 17, 1621. The process for his canonization was begun in 1627, but was delayed until 1930 for political reasons, stemming from his writings. In 1930, Pope Pius XI canonized him, and the next year declared him a doctor of the Church. Reflection The renewal in the Church sought by Vatican II was difficult for many Catholics. In the course of change, many felt a lack of firm guidance from those in authority. They yearned for the stone columns of orthodoxy and an iron command with clearly defined lines of authority. Vatican II assures us in The Church in the Modern World, “There are many realities which do not change and which have their ultimate foundation in Christ, who is the same yesterday and today, yes, and forever” (#10, quoting Hebrews 13:8). Robert Bellarmine devoted his life to the study of Scripture and Catholic doctrine. His writings help us understand that the real source of our faith is not merely a set of doctrines, but rather the person of Jesus still living in the Church today. Saint Robert Bellarmine is the Patron Saint of: Catechists Catechumens Click here for quotes from Catholic saints! Saint of the Day Copyright Franciscan Media

On Episode 8 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the September 2021 issue of Stroke: “Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor” and “Carotid Plaques From Symptomatic Patients Are Characterized by Local Increase in Xanthine Oxidase Expression.” She also interviews Drs. Jukka Putaala and Markku Kaste about their article “Should Tenecteplase be Given in Clinical Practice for Acute Ischemic Stroke Thrombolysis?”. Dr. Negar Asdaghi:         1) Are we ready to say goodbye to our old friend alteplase and replace it with a new one, tenecteplase, for acute stroke thrombolysis? 2) Does treatment of depression with SSRIs increase the risk of fractures in stroke patients? 3) When it comes to carotid intervention, should we continue offering treatment based on the degree of luminal stenosis, or are there better biomarkers in the horizon? These are some of the questions that we'll tackle in today's podcast. We're covering the best in Stroke. Stay with us. Dr. Negar Asdaghi:         Welcome back to Stroke Alert Podcast. My name is Negar Asdaghi. I'm an Associate Professor of Neurology at the University of Miami Miller School of Medicine and your host for the monthly Stroke Alert Podcast. For the September 2021 podcast, we have an exciting program where we discuss some of the controversies in stroke therapies. The September issue also contains a Focused Update with a set of articles and comprehensive reviews on the topic of genetics and stroke, organized by Professor Martin Dichgans, which I encourage you to review in addition to our podcast today. Later in today's podcast, I have the pleasure of interviewing Drs. Putaala and Kaste, from Helsinki Institute, to help us with a burning question of whether there's enough evidence now to use tenecteplase instead of alteplase for ischemic stroke thrombolysis. But first with these two articles. Dr. Negar Asdaghi:         Over a third of stroke survivors either have depressive symptoms or a formal diagnosis of depression. Selective serotonin reuptake inhibitors, or SSRIs, are the mainstay of depression treatment and the most common antidepressants prescribed in the U.S. In addition, in 2011, we had the results of the FLAME trial suggesting that early poststroke treatment with fluoxetine, a commonly prescribed SSRI, improves motor recovery and functional independence in stroke patients with motor deficit. Though these results were not replicated in the subsequent larger FOCUS trial, the use of SSRIs poststroke dramatically increased over the past decade. So what are the side effects of using SSRIs poststroke? It's a known fact that adult stroke survivors are more likely to experience bone fracture, and that there's some evidence that SSRIs may increase this risk. Dr. Negar Asdaghi:         So, in the current issue of the journal, Dr. Graeme Hankey and Joshua Jones, from Faculty of Health and Medical Sciences, University of Western Australia, in Perth, and colleagues aimed to answer this question with a systematic review and meta-analysis of randomized controlled trials that included an SSRI treatment for an adult patient with a previous hemorrhagic or ischemic stroke and included incident fractures, either as a primary or secondary study outcome, amongst other criteria. So they found four randomized controlled trials that fulfilled their research criteria. Three of them looked at the effects of fluoxetine, used at a dose of 20 mg per day for six months duration, on functional recovery and outcomes after stroke. And one trial, which has studied neuroregeneration in vascular protection by citalopram, either at a 10 mg or 20 mg daily dose also for six months duration, in patients with acute ischemic stroke. So three studies included with fluoxetine and one study included citalopram. Dr. Negar Asdaghi:         So, what they found was that although the risk of falls, seizures and recurrent stroke were not statistically increased with SSRI treatment, it was actually a significant increased risk of fractures with a risk ratio of 2.36 in patients treated with SSRI as compared to the placebo. Now, how the SSRIs will increase the risk of fractures is still unknown. There are multiple postulated mechanisms that are discussed in the paper, such as SSRIs potentially increasing spastic motor activity, causing orthostatic hypotension, dizziness, delayed reaction time or temporary imbalance or sleep disorders. But the most important mechanism to keep in mind is the possibility of SSRIs lowering bone mineral density. It's also important to note that the duration of exposure to SSRIs is an important predictor of factors. It's worth noting that the usual SSRI exposure in patients with the primary diagnosis of depression is a lot longer than the exposure time in these trials. Dr. Negar Asdaghi:         So, what are the top two takeaway points for stroke physicians? Number one: Fluoxetine and citalopram SSRIs, used for six months poststroke, double the risk of fracture as compared to placebo in this meta-analysis. Number two: While the mechanism of this association is still debated, fracture prevention should be an important discussion point when considering prescribing an SSRI to stroke patients. Dr. Negar Asdaghi:         We all know that carotid disease is a major cause of ischemic stroke. Now we have to keep in mind that the bulk of the literature in carotid disease are practically concentrated on the association between the degree of luminal stenosis and the risk of recurrent stroke. So, in practice, we constantly counsel and discuss risk of future ischemia in symptomatic and asymptomatic carotid disease based on the degree of stenosis that's less than 50%, or between 50% to 70%, or over 70%. Dr. Negar Asdaghi:         But what if we learn that some plaques can be active despite causing small or little stenosis? And conversely, some may be active despite being very large. There seems to be a growing literature that much of the recurrent strokes are occurring in destabilized plaques. And it turns out that there are actually biomarkers that could cause this destabilization, and we can actually measure them. Xanthine oxidase, or XO, is one of these biomarkers. XO is a key enzyme involved in degradation of purine into uric acid. Now I'm trying to simplify a complex subject here. Xanthine oxidase oxidizes the conversion of hypoxanthine into xanthine and xanthine into uric acid. Along the way, it also does create a whole bunch of reactive oxygen species such as superoxide and hydrogen peroxide, which can create tissue damage. Dr. Negar Asdaghi:         Now, how is XO and serum uric acid levels related to carotid disease? Well, it turns out that XO is enhanced in carotid arteries with evidence of atherosclerosis. Better yet, in animal models, inhibition of XO is associated with reduction in progression of atherosclerosis. So, in the current issue of the journal, Drs. Morsaleh Ganji and Valentina Nardi, from Departments of Cardiovascular Medicine and Anatomic Pathology of Mayo Clinic in Rochester, Minnesota, and colleagues set out to investigate whether carotid plaques from symptomatic patients had increased expression of xanthine oxidase than their asymptomatic counterparts. So, what they did was they looked at 88 patients undergoing carotid endarterectomy for symptomatic or asymptomatic carotid disease, part of the routine clinical practice, and then measured the XO expression by immunohistochemical staining in CA obtained specimens. Dr. Negar Asdaghi:         In addition, they collected a number of serum samples and other demographics and vascular risk factors from the participating patients. They found four major findings in their paper. Number one: XO expression was indeed higher in symptomatic carotid arteries. Number two: Symptomatic patients had a higher serum uric acid levels. Number three: Higher XO expression was inversely associated with the serum levels of HDL. Number four: The symptomatic plaques had higher amount of macrophages expressing XO. Dr. Negar Asdaghi:         Very interesting, but these findings were irrespective of the actual degree of luminal stenosis. In fact, the asymptomatic carotid plaques patients, as routine practice dictates, had a higher degree of luminal stenosis, but they had lower expression of XO and other associated findings. So what did we learn from this study? Well, there seems to be a strong association between certain biomarkers, in this case xanthine oxidase, and symptomatic state of carotid plaques, suggesting that perhaps in future we'll have other ways of measurements that may help us decide on carotid intervention rather than just the symptomatic state of the artery and the degree of stenosis. Dr. Negar Asdaghi:         It's been over 25 years since alteplase was approved as the thrombolytic agent of choice for treatment of patients with acute ischemic stroke. But in the past decade, tenecteplase, a genetically modified variant of alteplase with regulatory approval for treatment of ST-segment–elevation, myocardial infarction, has gained interest as an alternative reperfusion therapy for treatment of patients with acute ischemic stroke. Whether tenecteplase is ready to completely replace alteplase in clinical practice is certainly a burning question faced by the stroke community today. This was the subject of a lively debate at the most recent and entirely virtual 2021 International Stroke Conference, where a panel of experts reviewed the current evidence regarding the use of tenecteplase in acute ischemic stroke, examining data from animal models, preclinical studies to dose escalation studies and randomized trials, directly comparing tenecteplase with alteplase, as well as the collective clinical experience to date with this thrombolytic agent. Dr. Negar Asdaghi:         The proponents of change point out the many advantages of tenecteplase over alteplase, including its ease of use, increased fibrin specificity, longer half-time and its non-inferiority to alteplase in the head-to-head trials. On the other hand, the opponents caution stroke physicians, drawing attention to the inherent issues with the already completed clinical trials of tenecteplase, and argue that more data is needed before tenecteplase is considered as a thrombolytic agent of choice in routine clinical practice. Continuing on this debate in the September issue of the journal as part of the Controversies in Stroke series, Drs. Jeffrey Saver and May Nour provide opposing views to Drs. Dawn Kleindorfer and Mollie McDermott on the present evidence and current guidelines around tenecteplase use in acute ischemic stroke. Dr. Negar Asdaghi:         Acting as moderators, the senior authors of paper, Dr. Jukka Putaala, Head of Stroke Unit at Neurocenter, Helsinki University Hospital, and Dr. Markku Kaste, Emeritus Professor of Neurology at the University of Helsinki and past chairman of Neurocenter, Helsinki University Hospital, in Finland, provide us with the balancing remarks on the issue. I'm joined today by Professors Putaala and Kaste to give us an overview on the debate of tenecteplase versus alteplase. Is it time to make the switch? Good morning from sunny Florida and good afternoon to you both in Finland. Thank you for joining us on the podcast. I hope the weather is as beautiful in Helsinki today as it is here in Miami. Dr. Jukka Putaala:           Here it is not as warm as you have, but we have had a really beautiful summer, and at the moment, although it is also autumn, temperature is around 20 Celsius, so it's just great. Dr. Negar Asdaghi:         It's great to have you both. The paper outlines a generally recognized criteria to support the use of any new pharmacotherapy. Can you please start us off by reviewing the components of this criteria and tell us, please, how many checkmarks does TNK get on this checklist when considered as a reperfusion therapy in acute ischemic stroke? Dr. Jukka Putaala:           These eight criteria include a well-characterized mechanism of action; strong preclinical data; evidence of benefits and safety in a closely related clinical condition, which here is myocardial infarction; important practical advantages over existing agents; the clinical efficacy in how the patient has demonstrated in randomized trials; and endorsement by national practice guidelines. Also, support from regulatory authorities. And finally, clinical effectiveness, which has demonstrated in routine care. We think that tenecteplase for acute ischemic stroke meets actually all of these eight criteria. But we could also think that a smaller number of criteria will be enough to satisfy or meet, would be sufficient. Dr. Negar Asdaghi:         Perfect. So definitely many important steps, starting with the basics all the way to post-marketing clinical experience. Markku, now over to you. Can you remind us about the mechanism of action of tenecteplase? And what are some of the similarities and differences in terms of pharmacodynamic and pharmacokinetics with alteplase? Dr. Markku Kaste:           So alteplase catalyze plasminogen cleavage to plasmin and, in turn, degrades fibrin in thrombi, yielding clot lysis. TNK, compared to alteplase, is 14-fold greater fibrin activity and 80 times higher resistance to plasminogen activator inhibitor-1, which means it has a longer half-life, which is a major advantage. Patients need only one injection. In case you're compared to alteplase, when you had to have third dose injection and then one-hour infusion, which delay the care of patient, if the patient need thrombectomy. So it takes an hour for the infusion before patient can be transferred to thrombectomy, and time matters in brain infarction. So the faster you are, the better it is for patients. Dr. Negar Asdaghi:         Perfect. So more fibrin specificity, as you mentioned, and longer half-time for TNK. And in addition, TNK is not a new drug. In fact, there is over two decades' worth of experience with this in cardiology. Can you also tell us about this? And also some of the preclinical and animal studies that make TNK a potential candidate as a thrombolytic therapy in stroke? Dr. Markku Kaste:           In animal studies, both in vitro model of mural platelet deposits under arterial flow and a rabbit model using extracorporeal arterial-venous shunts, TNK was more potent, showing benefits up to three hours versus one hour when alteplase was used. So, it's a major benefit already in animal experiments and in the code team, of course, it will be transferred in clinical practice. So, in myocardial infarctions, in three randomized trials, including our 17,000 patients, TNK showed significant reduction for bleeding rates and similar intracerebral hemorrhage rates and 30-day mortality. Dr. Markku Kaste:           So, these facts support the use of TNK, also in ischemic stroke, the results from myocardial infarction, some steady encouraging. Although we have to keep in mind that myocardial infarction is very homogeneous disease, it's arterial occlusion, while ischemic stroke can be caused by the local occlusion just like myocardial infarction, but also from artery-to-artery thrombi or from a cardiac emboli. And these three [inaudible 00:17:43] mechanisms generate different kind of thrombi, so we need a better drug than alteplase, which really is effective, whatever is the etiology of the occlusion of brain artery. Dr. Negar Asdaghi:         Right. Thank you. Jukka, now over to you. Before we review the data from randomized trials of tenecteplase, can you please tell us about some of the practical advantages of tenecteplase over alteplase? We're comfortable with alteplase. Why should we make the switch? Dr. Jukka Putaala:           The key practical advantages arise from the fact that tenecteplase can be given as one single dose; it takes only one minute. And if you compare that to alteplase, you'll have to give the bolus first, and then following the bolus is 60 minutes infusion. And that also has many advantages in clinical practice, for example, if you have a patient with large vessel occlusion in a remote hospital, which is not thrombectomy-capable, you can give tenecteplase and then put the patient in the ambulance and transfer swiftly the patient to the thrombectomy center. While, when using alteplase, you have to start infusion, which you have to have the nursing staff that is capable of monitoring the infusion and taking care of any complications arising during the infusion and so forth. Dr. Jukka Putaala:           With tenecteplase, you can immediately transport the patient to a thrombectomy site after the bolus without any infusion-capable paramedics staff. Another practical advantage is that by using tenecteplase, you avoid the potential gap between the bolus and the infusion, which means that there is at least several minutes or longer gap in four out of five patients treated with alteplase. You can also think the other scenarios during this coronavirus era, and you have 15 patients with suspected or very fast coronavirus infection. By using bolus, you don't need to put nurses in the same room with the patients many times with the infusion if you use alteplase. Instead, you can use tenecteplase, it's only one single bolus, and you can go away and you don't have to be exposed to potential coronavirus infection. Dr. Negar Asdaghi:         So, many important advantages, as you mentioned. It seems very reasonable, then, to use tenecteplase in routine practice if it is indeed non-inferior to alteplase. Jukka, what dose of tenecteplase should be used for treatment of acute ischemic stroke patients? And we're definitely excited to hear about the head-to-head trials with tenecteplase versus alteplase. Dr. Jukka Putaala:           Well, the trial, the dose is 0.25 mg/kg or 0.4 mg/kg. It depends if you have LVO, if you review the evidence what we have now available, you have to use the lower dose in LVO patients. But you can use the higher dose in non-LVO patients. All of this arises from the evidence we have available right now. So, basically, five randomized trials have been completed, to date, comparing tenecteplase with alteplase in acute ischemic stroke. And shortly, if they pull out these five trials and compare primary outcome, which is modified Rankin Scale 0 to 1 versus prior, which means excellent outcome. Dr. Jukka Putaala:           So, when pulling out these five trials, 58% percent of patients rates excellent outcome versus 55% of alteplase, and this satisfied the criteria for non-inferiority. Regarding safety and secondary outcomes, major intracranial bleeding, mortality, this meta-analysis according to five trials shows similar results for tenecteplase and alteplase. You have to consider some details of this trial. I think Markku was going to quickly review some of the details of the science and doses used in these trials later on. Dr. Negar Asdaghi:         So, yes, this sounds great for tenecteplase, but so now over to you, Markku. As Jukka mentioned, do we hear a "not so fast for tenecteplase"? Is the current data enough to say goodbye to alteplase entirely and completely turn over to tenecteplase? What are some of the issues with the already completed trials? Dr. Markku Kaste:           It's not today, we cannot say goodbye to alteplase. As Jukka referred to those trials, there's no reason to go into these really deep details because the trials are quite small compared to ordinary clinical randomized trials studying stroke care. Like I don't want to give neuroprotection agents, for example. One larger trial was, let's say, reasonably well designed. But as to say that most of these trials are not really double-blind randomized clinical trials. And so the results which can be generated is not as reliable as double-blind trials because, of course, there are reasons, I mean, colleagues randomizing cases may think that, OK, a randomizing case and I'm not totally convinced about TNK. And I think this gentleman or this lady really needs effective thrombolytic agents, so I give alteplase, while if another patient with a mild symptom, same physician may think, OK, this stroke patient will recover no matter what, so let us randomize the patient. Dr. Markku Kaste:           So, it means these kind of unbalanced randomization provides data which is not really reliable. We had to have lots double-blinded randomized trials before it's time to say goodbye, if this double-blinded randomized trial verified that TNK beats alteplase. And, of course, we need also meta-analysis of those advanced trials, and these things can take time, although many guidelines, like AHA guidelines, European Stroke Organization guidelines, Chinese guidelines, Indian guidelines, they, in a way, how do you say, might recommend use of TNK, but I think we need more reliable scientific evidence before it's time to say goodbye to alteplase. Dr. Negar Asdaghi:         So, Jukka, Markku already alluded to this. I wanted you to review this for our listeners, the national practice guidelines and drug regulatory authority guidelines around the globe with regards to the issue of tenecteplase versus alteplase. Dr. Jukka Putaala:           Yeah, actually, already American, European, Chinese, Australian and Indian guidelines are recommending tenecteplase into the guidelines, which were recently published in 2019, between 2019 and 2021. What we can read from the guidelines is that tenecteplase can be considered over alteplase. But we have to remember that the strength of the recommendation will remain weak at present and quality of evidence is by the facts that we discussed of these five completely randomized trials and meta-analysis pulling out the data. Qualitative evidence remains slow, and, therefore, the wording in the guidelines is that it may be reasonable to choose or consider alteplase. Tenecteplase might be considered as an alternative to alteplase in certain conditions. Dr. Jukka Putaala:           The recommendations are a little bit mixed in the guidelines, but generally, in large vessel occlusions, the guidelines say that you could consider TNK over alteplase or even that you should consider TNK over alteplase in large vessel occlusion before proceeding to thrombectomy. However, in cases without large vessel occlusion, the statements are more mixed and they say tenecteplase might be considered or even that alteplase is preferred over tenecteplase until we have more evidence. Dr. Negar Asdaghi:         Thank you, Jukka. Markku, what should be our final takeaway message for the practicing stroke physicians at this point considering the use of tenecteplase in routine practice?   Dr. Markku Kaste:           Before your paper has been accepted and published in high-quality journal, it takes weeks, mostly it takes months, even a half a year. While in Stroke Conference, you get the most recent data, which is, let's say, generated last week or even the same day. So, when you want to really provide high-quality care of your patient, keep you updated. And then it's best for you and her, and it's better, of course, for your patient. International Stroke Conference and also European Stroke Conference, they are excellent places to get the most recent, yet unpublished, reliable information. Dr. Negar Asdaghi:         Professors Jukka Putaala and Markku Kaste, thank you for summarizing a large body of evidence for our listeners. We're definitely excited to learn how tenecteplase will ultimately stand against the old competitor and perhaps learn that both may be reasonable thrombolytic options, depending on the specifics of the clinical setting. Dr. Negar Asdaghi:         And this concludes our podcast for the September 2021 issue of Stroke. Please be sure to check the September table of contents for the full list of publications, including two special reports on consensus recommendations from the 11th STAIR Consortium, that is, Stroke Treatment Academic Industry Roundtable. Dr. Negar Asdaghi:         The first report is intended to enhance patient, clinician and policymaker comprehension at modified Rankin Scale findings in clinical trials and quality improvement initiatives. The second report from the STAIR Consortium is on top priorities for cerebroprotective studies, an important manuscript where the roundtable considered and presented a new paradigm for evaluation of putative therapies that may work together with recanalization treatments to improve outcome after ischemic stroke, with special attention to using the correct nomenclature, such as replacing the term "neuroprotection" with "cerebroprotection" when the intention of an investigation is to demonstrate that a new treatment benefits the entire brain, rather than neurons alone. Or replacing the term "time window" with "tissue window" or "target window" when selecting patients for recanalization therapies to enhance the notion that various elements of the neurovascular unit show vulnerability to ischemia evolving over different time scales in different brain regions. An important paradigm shift in ways we think of the brain under ischemic attack. With that, we invite you to continue to stay alert with Stroke Alert. Dr. Negar Asdaghi:         This program is copyright of the American Heart Association, 2021. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more, visit AHAjournals.org.

Ever wonder why some bariatric patients received extended VTE prophylaxis and others do not? Or what the ideal chemical VTE prophylaxis is for bariatric patients? All of your questions answered in this journal review discussion! Journal articles: A single-center comparison of extended and restricted thromboprophylaxis with LMWH after metabolic surgery: https://pubmed.ncbi.nlm.nih.gov/31641983/ Risk factors for postdischarge venous thromboembolism among bariatric surgery patients and the evolving approach to extended thromboprophylaxis with enoxaparin: https://pubmed.ncbi.nlm.nih.gov/33814315/

Doug goes around the NFL after Week 1. He weighs in on the QB controversy in Chicago, Mac Jones thriving in New England and tries to make sense of the Green Bay Packers. Hall of Fame NFL Executive and SiriusXM NFL Radio host Bill Polian joins the show. Bill tells stories from his legendary career across the CFL, USFL and the NFL. 

A bunch of Yes on Question 2 ads fell off a truck and Ben brought them to the podcast.

— —Watch the full episode here: http://watch.WithChude.comListen to the extended play podcast here: https://listen.withchude.comBuy #TheDailyVulnerable book here: https://www.amazon.com/dp/B089RJ7LJD/ref=cm_sw_r_cp_api_glt_GGHQEYBPFNPKH2RKZW4CSponsor a subscription for people who can't afford it here:Donate to the work via Patreon here:Partner with us through your institution or organisation here:Please subscribe to our YouTube Channel: https://youtube.com/channel/UC3C0OxzGKuFKJUpv-Dn-6fA—WithChude is a special series of targeted multimedia (video, audio, text, event) conversations and investigations that leverage the voice, network and passion of its host, Chude Jideonwo and his interviews, to underline social issues, raise social consciousness and spark social movements.Focused on narratives that enable and strengthen the mind (mental health), heart (emotional health) and spirit (spiritual health), its themes center on empathy, compassion, mindfulness, wellness, and food for the soul.#WithChude is a project of YNaija TV in partnership with Joy, Inc.For inquiries or issues with the platform, please call +2349035998080 or email info@withchude.com.#WithChude#MindHeartSpirit#LetsBeHumanTogether See acast.com/privacy for privacy and opt-out information.

OLYMPIC TRIALS CONTROVERSIES This week, we have a commission from Club Gym Nerd member Jasmine, who asked for an episode on the history of US Olympic Trials—how teams were selected and all the major scandals. And there have been plenty. 1980 - Olympic boycott hypocrisy and what happens when gymnasts tie for the last spot? (Or have alligators?) 1984 - The case of Dianne Durham and the Olympic petition 1988 - The Perils of Rank Order: The Early Years 1992 - The back-room meeting that kept Kim Kelly off the Olympic team 1996 - Only controversial if you're a Forster? 2000 - Atler. Nuff said. The Martha Years - Were teams really chosen months in advance? Plus, we make our proposals for an ideal Olympic team selection process for the United States JOIN CLUB GYM NERD Join Club Gym Nerd or buy a gift membership for access to Behind the Scenes episodes. Behind the Scenes: Kensley's Wedding Behind The Scenes After Olympic Trials We Have Olympic Teams! Olympic Trials Day Two for Men & Women Live From Olympic Trials: Men & Women Day One Behind The Scenes: Post-Championships Debrief Behind The Scenes: Day Two US Women's Championships 2021 Behind The Scenes: Day One US Women's Championships 2021 Buy our awesome clothing and gifts here. We have masks too! And Pride gear! RELATED EPISODES Vanessa Atler Jamie Datzscher How to Stage a Gymnastics Protest Tokyo Olympics Recap

Over a two-week period, the Supreme Court issued three momentous rulings on its shadow docket: one on abortion, another on evictions, and a third on asylum policy. SCOTUSblog's publisher and co-founder, Tom Goldstein, joins the podcast to break down all three. See acast.com/privacy for privacy and opt-out information.

Bariatric Surgery: life-saving or irreversibly damaging? At least among Dietitian's, bariatric surgery is pretty controversial. On the one hand, surgery may be the only means of achieving life-saving weight loss for patients with obesity. On the other hand, the surgeries often cause life-long problems with digestive function.  This can impact quality of life, and even hormone balance. My guest this episode is Katie Chapmon, RD.  Katie has extensive experience with bariatric patients.  This experience led to an expertise in the connection between digestion and hormones.  Specifically, Katie often works with people who suffer from both IBS and PCOS.  In addition to her clinical practice, Katie provides practitioner education to clinicians who work with the bariatric surgery population. Katie Chapmon, MS, RD is an award-winning Registered Dietitian Nutritionist specializing in Bariatric Nutrition, GI Issues and Hormonal Health and with 10+ years of hands-on clinical experience for leading medical providers. She is the proud recipient of the 2010 Recognized Young Dietitian of the Year Award and 2018 Excellence in Weight Management Practice Award through the Academy of Nutrition and Dietetics. She spent the first decade of her career as the lead dietitian for Kaiser Permanente Southern California. For the past several years, she has been working with industry partners and consumers to improve nutrition education within the field, and maintains a virtual private practice. In April 2021, she launched Bariatric Nutrition Pro – to provide healthcare practitioners education to start (or continue!) their bariatric career with the confidence and knowledge to succeed. She currently serves as the Chair of the American Society of Metabolic and Bariatric Surgery Integrated Health Clinical Issues Committee, Chapter author of the 3rd Edition of the Academy of Nutrition and Dietetics Pocket Guide to Bariatric Surgery. She is a national speaker and enjoys time hiking and cooking in the kitchen.  In this episode, we discuss: How Katie's work in bariatrics made her an expert the connections between digestive health and hormone balance How IBS and PCOS are related Why bariatric surgery is controversial Why and when bariatric surgery may be needed Common mistakes before and after bariatric surgery The long-term effects of bariatric surgery Work with Katie: www.katiechapmon.com Get practitioner education for working with bariatric patients: www.bariatricnutritionpro.com  Check out the full episode at: https://erinskinner.com/empowerednutrition/bariatricsurgery Please review the Empowered Nutrition Podcast on Apple Podcasts or wherever you listen! Then, send me a screenshot of your positive review to erin@erinskinner.com as a DM on Instagram (erinskinner_rd) .  Include a brief description of what you're working on with your health and/or nutrition and I'll send you a free custom meal plan!  Also, I'm accepting new clients for functional nutrition!  Book a free chemistry call to discuss your story and see if we're a good fit HERE. Follow me on Facebook | Instagram | Pinterest

Dotun's joined by Tim Vickery, Mina Rzouki and Paul Sarahs to discuss the Brasil v Argentina controversy, Ronaldo and World Cup possibilities from the South American teams.

Welcome to the Mini-Break podcast powered by Tennis Point. This is your daily podcast for the biggest storylines, results, and controversies from the tennis world. Cracked Racquets Editor-in-Chief Alex Gruskin recaps Day 7 of the 2021 US Open. He offers his response to the ending of Krejcikova/Muguruza, discusses the youth movement in New York, shares his thoughts on the magical run of Botic Van De Zandschulp, previews Day 8, and so much more!! Don't forget to give a 5 star review on your favorite podcast app! In addition, add your twitter/instagram handle to the review for a chance to win some FREE CR gear!! This episode brought to you by: Tennis Point Discounted Tennis Apparel, Tennis Racquets, Tennis Shoes & Equipment from Nike, adidas, Babolat, Wilson & More! Visit their store today and use the code "CR15" at checkout to save 15% off Sale items. Some Exclusions (MAP Exceptions) apply and code will not work on those items. This code will add 1 FREE CAN of WILSON Balls to the cart at checkout.  Lucky Racket The hub for tennis fans, based out of Dayton, OH. Our mission is to make everyone smile when they see our products on and off the tennis courts! Get 15% OFF by using our promo code "Cracked15" at luckyracquet.com. Har-Tru Whether it's the red clay courts of the Houston ATP, the green clay courts of the Charleston WTA, or the official hardcourt of World TeamTennis, Har-Tru has you covered. If you're looking to build a court, convert a hardcourt to clay, or simply resurface your hardcourt, work together with Har-Tru in their mission to lead the tennis industry by creating better places to play!! To learn more about their state-of-the-art surfaces, along with their full catalog customizable on-court accessories, checkout hartru.com or call (877) 442-7878 today.” Tennis Channel Podcast Network Visit https://www.tennis.com/pro-game/podcasts/ to stay current on the latest tennis news and trends and enjoy in-depth analysis and dynamic debates. Find Cracked Racquets Website: https://www.crackedracquets.com Instagram: https://instagram.com/crackedracquets Twitter: https://twitter.com/crackedracquets Facebook: https://Facebook.com/crackedracquets YouTube: https://www.youtube.com/channel/UC12ZE3jU0n52JkeWV1TB21A Email Newsletter: https://www.crackedracquets.comDon't forget to give a 5 star review with your twitter/instagram handle for a chance to win some FREE CR gear!! Learn more about your ad choices. Visit megaphone.fm/adchoices

The Supreme Court is typically thought to be out most of the summer. But it issued a momentous opinion on abortion rights that came from the court's so-called "shadow docket." For this special episode of Cases and Controversies, hosts Jordan Rubin and Kimberly Robinson discuss where this opinion came from and why it came outside of the court's normal operating procedures. They also talk about how the justices came down in this case and what this ruling means for the liberal justices' prospects moving forward.

In this final episode in our series on the Traditionalist movement, we detail the growth of the traditionalist orders in communion with Rome, the growth of traditionalism during the reign of Pope Benedict XVI, and finally, end with a brief examination of Francis' motu proprio Traditionis Custodes, and what it means for the traditionalists and the Church as a whole. Please subscribe to our podcast on Anchor and check out Controversies in Church History on our other platforms: LINKS: YouTube Website SOCIAL: Facebook Twitter --- Support this podcast: https://anchor.fm/churchcontroversies/support

Dr. Sosa discusses the rise in thyroid cancer cases, patient risk factors, the financial challenges associated with long-term treatment and testing, and future research directions in the field.

Controversies, stinky fiances, ultra realistic ultra expensive, family drama and Itsy Bitsy!

It's been some time since the last episode came out, but Dream Green is back and better than ever. In this episode, Grace will discuss Reducing, Reusing, and Recycling. She will also talk about the controversies of recycling, myths of reducing, and the benefits of implementing the 3 R's into your daily life.  Check out daretodreamgreen.com to see what Grace has been doing to help wildlife and the environment. Or, check out @gracegonegreen on Instagram. 

Dave Chappelle jokes about his controversies in his Netflix special, "Equanimity and the Bird Revelation".

In the latest episode in our series on the Catholic Traditionalist movement, we pick up the narrative in the reign of John Paul II, where the new prefect of the Congregation for the Doctrine of the Faith, Joseph Ratzinger, brings a sympathetic voice into the curia. Meanwhile, divisions arise within the Society of St. Pius X, even as negotiations with Rome continue, and Una Voce International continues to press for the legalizing of the Old Roman missal. But negotiations breakdown, leading to excommunication, the division of Marcel Lefebvre's followers and the return of some to communion with Rome. Please subscribe to our podcast on Anchor and check out Controversies in Church History on our other platforms: LINKS: YouTube Website SOCIAL: Facebook Twitter --- Support this podcast: https://anchor.fm/churchcontroversies/support

Dr. Longman has written prolifically about the book of Genesis, but there is an ongoing rub in Christian communities about how to handle the creation narratives in Genesis 1–2. Can we read "the simple meaning" of the text? Is it enough to "just have the Bible" and not take the time to dig deeper in the ancient Near Eastern text? Plus, the New Testament mentions figures like Adam and Eve, so is that proof of the literal first humans?Find out more about Dr. Tremper Longman III and read his book Confronting Old Testament Controversies.Contact me through Narrative of Place Learn more about me and sign up for upcoming tours of Israel/Palestine.Join Cyndi Parker's  Patreon Team! 

To ITB, or Not To ITB? (Iliotibial Band Controversies, Conditions, and Approaches) Whitney and Til unfold the controversies, compare thoughts, and share approaches for working with the iliotibial band. Download the free handout!  Topics include:  Little-known facts, well-known myths, and over-heated controversies about the ITB,  When and why would (or wouldn't) we work, roll, or massage the ITB (aka the iliotibial tract or fascia lata)?  Hands-on techniques for some of the most common ITB-related client complaints.  Get the HANDOUT and full transcript at Til or Whitney's sites, plus sign up for Til's upcoming Leg Knee & Foot course!  Resources and references discussed in this episode: Baker RL, Fredericson M. Iliotibial Band Syndrome in Runners. Biomechanical Implications and Exercise Interventions. Phys Med Rehabil Clin N Am. 2016;27(1):53-77. doi:10.1016/j.pmr.2015.08.001 Aderem J, Louw QA. Biomechanical risk factors associated with iliotibial band syndrome in runners: A systematic review Rehabilitation, physical therapy and occupational health. BMC Musculoskelet Disord. 2015;16(1):7-9. doi:10.1186/s12891-015-0808-7 Fairclough J, Hayashi K, Toumi H, et al. The functional anatomy of the iliotibial band during flexion and extension of the knee: implications for understanding iliotibial band syndrome. J Anat. 2006;208(3):309-316. doi:JOA531 [pii]10.1111/j.1469-7580.2006.00531.x Podcast ITB image used under license by the National Library of Medicine Visible Human Project. Arrows show location of ITB. Til Luchau's “Principles: Leg Knee & Foot” live-online course (join live thru mid-September, or later by recording)  Download this episodes free handout for full references and more Whitney Lowe's site: AcademyOfClinicalMassage.com  Til Luchau's site: Advanced-Trainings.com  Sponsor Offers:  Books of Discovery: save 15% by entering "thinking" at checkout on booksofdiscovery.com.  ABMP: save $24 on new membership at abmp.com/thinking.  Handspring Publishing: save 20% by entering “TTP” at checkout at handspringpublishing.com.  About Whitney Lowe  | About Til Luchau  |  Email Us: info@thethinkingpractitioner.com (The Thinking Practitioner Podcast is intended for professional practitioners of manual and movement therapies: bodywork, massage therapy, structural integration, chiropractic, myofascial and myotherapy, orthopedic, sports massage, physical therapy, osteopathy, yoga, strength and conditioning, and similar professions. It is not medical or treatment advice.)

The critics of Kaliri vs. the defenders -famous Gedolim, all of them.

In this episode of GG over EZ, The Dream Team discusses The Green Knight, Mr. Fruit's health dilemmas, God of War, Wisdom Teeth virality, stealing Lebron James' head, as well as much more like Q&A! Enjoy! Patreon: https://www.patreon.com/GGEZPodcast Reddit: reddit.com/r/MrFruit Mr. Fruit: http://www.youtube.com/user/MyMisterFruit http://www.youtube.com/c/MoreMrFruit https://www.youtube.com/channel/UC_mFMxLmX1y8mQjzsan2Ltg http://www.twitch.tv/MyMisterFruit http://www.twitter.com/MrFruitYT Rhabby_V: http://www.twitch.tv/Rhabby_V http://www.twitter.com/Rhabby_V BlueWestlo: http://www.twitch.tv/BlueWestlo http://www.twitter.com/BlueWestlo Mr. Fruit, Rhabby_V and BlueWestlo take you on a magical ear-adventure every week on GG over EZ with discussions ranging from games to life stories every Sunday. They frequently create content on Mr. Fruit's YouTube channel under the guise "The Dream Team". Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we will look at some of the priests (and a few bishops) who resisted the suppression of the old Roman rite during the 1960s and 70s. We discuss how arguments over the liturgy inevitably involved disputes about the Second Vatican Council, and the reforms implemented in the immediate post-conciliar period, as well as the series of events that would lead to the separation of the Society of St. Pius X from communion with Rome. Please subscribe to our podcast on Anchor and check out Controversies in Church History on our other platforms: LINKS: YouTube Website SOCIAL: Facebook Twitter --- Support this podcast: https://anchor.fm/churchcontroversies/support

The QB position is dominating headlines in the CFL, whether it be the Michael Reilly/Nathan Rourke situation in BC, questions around who will start in Hamilton and Toronto, or the 0-2 Alberta teams. To help us make sense of it all is the CFL on TSN's Farhan Lalji.

Questions continue to be raised about the “Ice Dam” that withheld “Lake Missoula” and their role in the catastrophic Ice Age Megafloods that ravaged the Pacific Northwest around 13,000 years ago. Going “Back to Bretz” to consider again the likelihood that the floods were augmented greatly by sudden rushes of meltwater from the Cordilleran Ice Sheet that loomed directly to the north of the entire suite of megaflood features, Randall shows again and again how this makes perfect and obvious sense, although it is totally ignored by the standard model that describes the flood scenario. With his diagrams and multiple quotes from published geologists, RC stresses the impossibility of ice withholding a lake over 2000 feet deep. Kosmographia Ep070 The Randall Carlson Podcast with Brothers of the Serpent – Kyle and Russ, Creative Director Llauraa, producer and GeocosmicREX admin Bradley, from 6/12/21. LINKS:  Announcements about events, tours and more: http://randallcarlson.com/newsletter  (Monthly) Contact at the Clark Fork June '22 http://contactatthecabin.com/montana  Full listing of scientific papers about the Younger Dryas Impact Hypothesis: https://cosmictusk.com USGS detailed maps of North America: https://apps.nationalmap.gov/viewer/  CBD RECOMMENDED - Listen to Randall's experience with “CBD from the gods” after the mid-break at 50:00. They have some special deals going on right now, and in addition, for the Kosmographia audience - you can also get FREE shipping on your order!  Use code: “RCshipsFREE” (not case sensitive) when you check out at https://www.cbdfromthegods.com  Support Randall Carlson's efforts to discover and share pivotal paradigm-shifting information! Improve the quality of the podcast and future videos. Allow him more time for his research into the many scientific journals, books, and his expeditions into the field, as he continues to decipher the clues that explain the mysteries of our past, and prepare us for the future... Make a one-time donation thru PayPal, credit/debit card or other account here: https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=8YVDREQ9SMKL6&source=url http://www.RandallCarlson.com has the podcast, RC's blog, galleries, and products to purchase! T-shirts available here: https://randallcarlson.com/product-category/apparel/  Podcast crew email: Kosmographia1618@gmail.com Info on upcoming trips with Randall and the crew: TOURS@RandallCarlson.com Offer your time/services/accommodations here: VOLUNTEER@RandallCarlson.com Add to the expanding library of evidence here: RESEARCH@RandallCarlson.com Small class lectures "Cosmography 101" from '06-'09 on Brad's original channel: https://youtube.com/geocosmicrex     Kosmographia logo and design animation by Brothers of the Serpent. Check out their podcast: http://www.BrothersoftheSerpent.com/ Theme “Deos” and bumper music by Fifty Dollar Dynasty: http://www.FiftyDollarDynasty.net/ Video recording, editing and publishing by Bradley Young with YSI Productions LLC (copyrights), with audio mastered by Kyle Allen. CBD FROM THE GODS LINK:  http://www.cbdfromthegods.com          COUPON CODE: RCshipsFREE Chapters: 0:00      Ice Sheet Margin WA 14:44    Back to Bretz idea 28:44    18 cubic-miles/hour! 38:20    Many Separate Floods? 49:59    CBD updates 55:00    Ice Dam Viability 1:13:52  Clark Fork Dam? 1:32:18  Ice/berg Jamming 1:38:02  Missoula a lake? 1:43:00  Announcements #Megafloods #IceDam #IceAgeFloods #Missoula #Spokane #PendOreille #ClarkFork #WallulaGap

About The Guest:Marcie Elisabeth Thieriot Elisabeth Thieriot has been recognized worldwide for her work as an innovator, author, filmmaker, educator and leading professional in business development, and for her dedication to philanthropy. She is currently President of Lions Gate Corporation, Founder and CEO of Replete Skincare, President of Elicosma Productions, LLC, and Publisher of FSHN Magazine. Elisabeth authored the popular book “Be Fabulous at Any Age,” and co-authored “Discovering Excellent Health.” In her philanthropic work, Elisabeth actively works with Operation Diana, and is a charitable supporter of The Redwoods, Raphael House, Kids' Turn, Edgewood Foundation, and Prince of Wales' Charitable Foundation. To read more about Elisabeth Thieriot, go to: www.linkedin.com/in/elisabeth-thieriot-05212417 www.repleteskincare.com www.facebook.com/ArtofSeasonalLiving About The Host:  Tonia DeCosimo is the founder of P.O.W.E.R.- Professional Organization of Women of Excellence Recognized and editor-in-chief of P.O.W.E.R. Magazine. She is also an author, columnist, entrepreneur, and women's empowerment advocate. With 30 years in the publishing and advertising business, Tonia enjoys listening and learning from powerful women. She believes that their hard work and dedication deserves acknowledgement and recognition. One of Tonia's passions is to inspire and empower women and help them become their best.   https://toniadecosimo.com/about-tonia-1 (Read more..)

OTB AM looks back at an extraordinary evening in Corke Park. OTB AM with Gillette | #BestFaceForward

The CCP in China remains opposed to any thorough investigations of the origins of SARS2, which isn't surprising given the nature of that domination system. Joe Rogan had an “emergency podcast” about nonsensical YouTube take-downs, public health corruption and controversies, and ivermectin. Governmental systems such as the FDA and its Emergency Use Authorization for Covid-19 …

Dr. Brian Hooker is an Associate Professor of Biology at Simpson University. He specializes in microbiology and biotechnology and has a keen interest in the importance of inoculation and the safety of childhood inoculation. He has written numerous articles about childhood inoculation side effects including allergies, developmental delays, infections, and neurodevelopmental disorders. He is currently interested in the association between the cv1-9 inoculation and subsequent health issues such as the number of adverse events and deaths thought to be related to the inoculation. Click on play to learn: How inoculation has become lucrative for pharmaceutical companies. What studies of uninoculated children reveal about the side effects of childhood inoculation. What long-term and acute effects are being associated with childhood and cv1-9 inoculation. Childhood inoculations are meant to protect children from serious and potentially fatal diseases such as measles, polio, diphtheria, mumps, rubella, and others. Sometimes, a child has an adverse reaction after getting inoculate that may be linked to the inoculation itself. Some of those reactions include developmental delays, autism, allergies, ear infections, ADD, and ADHD. However, the medical community does not acknowledge any links between childhood inoculation and these types of reactions. Dr. Hooker has an interest in medical epidemiology and adverse events and has been doing research on childhood inoculation and possible reactions. Using data retrieved through 2016 from the Inoculation Safety Datalink, his studies have found that uninoculated children seem to have fewer chronic disorders and appear to be healthier than children who received inoculations on schedule. Some adverse reaction events surrounding the cv1-9 inoculation have lead to questions about the safety, testing, and effectiveness of the inoculation. The issue of mandated inoculation by corporations and educational institutions and the possibility of a inoculate passport have raised questions relating to the infringement of the civil rights of U.S. citizens. Dr. Horn discusses these issues, the power of big pharma companies, and inoculation pros and cons. To learn more visit: childrenshealthdefense.org childrenshealthdefense.org/defender Episode also available on Apple Podcasts: apple.co/30PvU9C